Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya

被引:39
作者
Njomo, Doris W. [1 ]
Mukoko, Dunstan A. [2 ]
Nyamongo, Nipher K. [1 ]
Karanja, Joan [3 ]
机构
[1] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya
[2] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya
[3] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya
基金
比尔及梅琳达.盖茨基金会;
关键词
DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA;
D O I
10.1371/journal.pone.0083413
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.
引用
收藏
页数:9
相关论文
共 50 条
[21]   Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria [J].
Richards, Frank O. ;
Eigege, Abel ;
Miri, Emmanuel S. ;
Kal, Alphonsus ;
Umaru, John ;
Pam, Davou ;
Rakers, Lindsay J. ;
Sambo, Yohanna ;
Danboyi, Jacob ;
Ibrahim, Bako ;
Adelamo, Solomon E. ;
Ogah, Gladys ;
Goshit, Danjuma ;
Oyenekan, O. Kehinde ;
Mathieu, Els ;
Withers, P. Craig ;
Saka, Yisa A. ;
Jiya, Jonathan ;
Hopkins, Donald R. .
PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (10)
[22]   Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India [J].
Ratna, P. ;
Sinha, Abhinav ;
Pati, Sanghamitra ;
Sahoo, Prakash Kumar .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[23]   Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India [J].
Babu, B ;
Kar, SK .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (06) :702-709
[24]   COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA [J].
Kisoka, William J. ;
Tersbol, Britt Pinkowsky ;
Meyrowitsch, Dan W. ;
Simonsen, Paul E. ;
Mushi, Declare L. .
JOURNAL OF BIOSOCIAL SCIENCE, 2016, 48 (01) :94-112
[25]   Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted? [J].
Rebollo, Maria P. ;
Mohammed, Khalfan A. ;
Thomas, Brent ;
Ame, Shaali ;
Ali, Said Mohammed ;
Cano, Jorge ;
Gonzalez Escalada, Alba ;
Bockarie, Moses J. .
PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (03)
[26]   Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania [J].
Kisoka, William J. ;
Simonsen, Paul E. ;
Malecela, Mwelecele N. ;
Tersbol, Britt P. ;
Mushi, Declare L. ;
Meyrowitsch, Dan W. .
PLOS ONE, 2014, 9 (10)
[27]   Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil [J].
Lima, Ana Wladia ;
Medeiros, Zulma ;
dos Santos, Zailde Carvalho ;
da Costa, Gertrudes Monteiro ;
Braga, Cynthia .
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (06) :745-750
[28]   ADVERSE REACTIONS FOLLOWING MASS DRUG ADMINISTRATION WITH DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR LYMPHATIC FILARIASIS ELIMINATION IN WEST SUMATERA, INDONESIA [J].
Widiastuti, Dyah ;
Kesuma, Agung Puja ;
Jastal ;
Kusrini, Ina ;
Wijayanti, Siwi Pramatama Mars ;
Dhewantara, Pandji Wibawa .
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2021, 52 (01) :1-10
[29]   Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration [J].
Simonsen, Paul E. ;
Derua, Yahya A. ;
Magesa, Stephen M. ;
Pedersen, Erling M. ;
Stensgaard, Anna-Sofie ;
Malecela, Mwelecele N. ;
Kisinza, William N. .
PARASITES & VECTORS, 2014, 7
[30]   Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana [J].
Biritwum, Nana-Kwadwo ;
Garshong, Bertha ;
Alomatu, Bright ;
de Souza, Dziedzom K. ;
Gyapong, Margaret ;
Kyelem, Dominique .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (05)